ALNYLAM PHARMACEUTICALS INC (ALNY)       233.37  +3.62 (+1.58%)

233.37  +3.62 (+1.58%)

US02043Q1076 - Common Stock - After market: 238.07 +4.7 (+2.01%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
960.92M844.29M492.90M219.80M74.90M
Non Recurring Items
N/AN/AN/A0.0020.60M
Cost Of Goods
155.22M140.14M78.10M25.10M1.80M
Gross Profit
805.70M704.14M414.80M194.70M73.10M
Operating Expenses
1.60B1.41B1.24B1.13B887.80M
Operating Income
-791.02M-708.65M-828.40M-939.40M-814.70M
Interest Expense
-286.88M-124.18M-72.70M33.40M29.30M
Income Before Taxes
-1.18B-852.14M-855.60M-885.30M-760.70M
Income Tax
1.85M680.00K2.70M900.00K1.60M
Net Income
-1.18B-852.82M-858.30M-886.10M-761.50M
EBITDA
-749.49M-661.09M-793.60M-922.20M-808.30M
 
Per Share Data
EPS Diluted Total Ops
-9.77-7.20-7.46-8.11-7.57
Non GAAP EPS
-9.14-7.12-7.66-8.15-7.76
 
Statistics
Gross Profit Margin
83.85%83.40%84.16%88.58%97.60%
Profit Margin
-123.02%-101.01%-174.13%-403.14%-1016.69%
Operating Profit Margin
-82.32%-83.93%-168.07%-427.39%-1087.72%

All data in USD

Charts